Bovine Pericardial Valve Market Report 2026

Bovine Pericardial Valve Market Overview

• Bovine Pericardial Valve market size has reached to $1.57 billion in 2025 • Expected to grow to $2.53 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: The Rising Prevalence Of Cardiovascular Diseases Driving The Market Growth Due To Increasing Sedentary Lifestyles • Market Trend: Advancements In Next-Generation Bovine Pericardial Aortic Valves Enhancing Surgical Efficiency And Long-Term Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bovine Pericardial Valve Market?

A bovine pericardial valve is a bioprosthetic heart valve made from cow (bovine) pericardial tissue, used in cardiac surgeries to replace diseased or damaged natural valves. It offers strong biocompatibility, improved blood flow performance, and durability, while being engineered to reduce calcification and structural degradation for better long-term patient outcomes. The main product types of bovine pericardial valve include surgical valves and transcatheter valves. Surgical valves refer to biologic heart valve replacements derived from bovine pericardial tissue, used in open-heart procedures to restore normal cardiac blood flow. The different age groups include pediatric and adult. The various applications involved are aortic valve replacement, mitral valve replacement, and tricuspid valve replacement, and they are used by several end users such as hospitals, cardiac centers, and ambulatory surgical centers.

What Is The Bovine Pericardial Valve Market Growth Forecast?

The bovine pericardial valve market size is expected to see rapid growth in the next few years.It will grow to $2.53 billion by 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for minimally invasive and transcatheter procedures, rising global geriatric population driving valve replacement needs, advancement in tissue engineering and biomaterial innovation, growing preference for durable and low anticoagulation valve solutions, expanding healthcare infrastructure and cardiac care accessibility in emerging markets.Major trends in the forecast period include increasing adoption of advanced bioprosthetic heart valve materials with enhanced durability, rising demand for minimally invasive valve replacement procedures, growing focus on anti calcification treatment technologies in tissue valves, expansion of transcatheter heart valve implantation procedures, increasing clinical preference for long lasting biologic valve substitutes over mechanical valves.

Global Bovine Pericardial Valve Market Segmentation

1) By Product Type: Surgical Valves, Transcatheter Valves 2) By Age Group: Pediatric, Adult 3) By Application: Aortic Valve Replacement, Mitral Valve Replacement, Tricuspid Valve Replacement 4) By End User: Hospitals, Cardiac Centers, Ambulatory Surgical Centers Subsegments: 1) By Surgical Valves: Aortic Valve, Mitral Valve, Tricuspid Valve, Pulmonary Valve 2) By Transcatheter Valves: Transcatheter Aortic Valve, Transcatheter Mitral Valve, Transcatheter Pulmonary Valve, Transcatheter Tricuspid Valve

What Are The Drivers Of The Bovine Pericardial Valve Market?

The rising prevalence of cardiovascular diseases is expected to propel the growth of the bovine pericardial valve industry going forward.Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including coronary artery disease, ischemic heart disease, heart failure, and valvular conditions, and remain the leading cause of global morbidity and mortality.The prevalence of cardiovascular diseases is rising primarily due to increasing sedentary lifestyles.Reduced physical activity slows metabolism and promotes obesity, which significantly elevates the risk of heart-related conditions.The bovine pericardial valve supports cardiovascular diseases by providing a durable and biocompatible solution for surgical valve replacement in patients with CVDs, especially in cases of valvular heart disease requiring long-term performance and reduced risk of reoperation.For instance, in September 2025, according to the American College of Cardiology, a US-based medical association, cardiovascular disease deaths worldwide rose to 19.2 million in 2023, up from 2022.Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the bovine pericardial valve industry. The increasing preference for minimally invasive procedures is expected to propel the growth of the bovine pericardial valve industry going forward.Minimally invasive procedures are medical interventions designed to reduce trauma to the body by using small incisions or natural body openings, resulting in less pain, lower risk of complications, and faster recovery compared to traditional open surgeries.The growing preference for minimally invasive procedures is largely driven by technological advancements in surgical tools and techniques, which have enabled physicians to perform complex cardiac interventions with greater precision and significantly reduced patient recovery time.The rising adoption of minimally invasive approaches directly increases the utilization of bovine pericardial valves, as these tissue-based valves are well-suited for deployment through catheter-based and minimally invasive cardiac surgery platforms.For instance, in June 2024, according to the American Society of Plastic Surgeons (ASPS), a US-based professional medical organization, more than 11,000 board-certified plastic surgeons worldwide, minimally invasive procedures grew by 7% in 2023 compared to 2022, with nearly 25.4 million such procedures performed in the United States in 2023, up from approximately 23.7 million in 2022.Therefore, the increasing preference for minimally invasive procedures is driving the growth of the bovine pericardial valve industry.

Key Players In The Global Bovine Pericardial Valve Market

Major companies operating in the bovine pericardial valve market are Shanghai Cingular Biotechnology Co Ltd, Medtronic plc, Edwards Lifesciences Corporation, Meril Life Sciences Pvt Ltd, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Braile Biomédica Indústria Comércio e Representações SA, Venus Medtech Hangzhou Inc, Peijia Medical Limited, Artivion Inc, Balance Medical Limited, HighLife SAS, Maverick Biosciences Inc

Global Bovine Pericardial Valve Market Trends and Insights

Major companies operating in the bovine pericardial valve market are focusing on developing advanced products, such as next-generation surgical aortic tissue valves, to enhance procedural efficiency and long-term patient outcomes. A next-generation surgical aortic tissue valve is an advanced bioprosthetic valve designed to replace a diseased aortic valve with improved durability and performance. It enhances blood flow efficiency and reduces complications, supporting better patient outcomes. For instance, in April 2024, Medtronic, an Ireland-based medical technology company, launched the Avalus Ultra Valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support lifetime patient management. The Avalus Ultra Valve features advanced tissue treatment for improved durability, optimized leaflet design for enhanced hemodynamic performance, and user-friendly handling characteristics that simplify surgical procedures, contributing to consistent clinical outcomes and long-term valve reliability.

Regional Insights

North America was the largest region in the bovine pericardial valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bovine Pericardial Valve Market?

The bovine pericardial valve market consists of sales of bioprosthetic heart valve leaflets, pericardial tissue patches, cardiac repair membranes, and valve reconstruction grafts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Bovine Pericardial Valve Industry?

The bovine pericardial valve market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bovine pericardial valve industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Bovine Pericardial Valve Market Report 2026?

The bovine pericardial valve market research report is one of a series of new reports from The Business Research Company that provides bovine pericardial valve market statistics, including bovine pericardial valve industry global market size, regional shares, competitors with a bovine pericardial valve market share, detailed bovine pericardial valve market segments, market trends and opportunities, and any further data you may need to thrive in the bovine pericardial valve industry. This bovine pericardial valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.